trial
as of 2026-07-01Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia
NCTId NCT00763438
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
18 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2007-11
Primary completion
2010-07
Eligibility
ALL · 18 Years
Interventions & indications
Drugs
Indications
Sponsors
H. Lundbeck A/SLead Sponsor
Sites
1 total
Allonnes, France
Facts & assertions
4 sourced
Enrollment
18
Phase
PHASE4
Primary Completion Date
2010-07
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
indication
indication